Key points are not available for this paper at this time.
In the face of an epidemic of misuse of prescription opioids and related deaths, many states have created prescription-drug monitoring programs to track prescribing of controlled substances. As such programs are developed, expanded, or retooled, reanalysis is in order.
Perrone et al. (Thu,) studied this question.